B6;129-Spo11tm(Spo11-beta_b)Mbrc/Cnrm

Status

Under development - register interest

EMMA IDEM:15268
Citation informationRRID:IMSR_EM:15268 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameB6;129-Spo11tm(Spo11-beta_b)Mbrc/Cnrm
Alternative nameC57/129Spo11_beta_b_ki/+
Strain typeTargeted Mutant Strains
Allele/Transgene symbolSpo11beta-b_ki
Gene/Transgene symbolSpo11

Information from provider

ProviderMarco Barchi
Provider affiliationBiomedicine and Prevention, University of Rome Tor Vergata
Genetic informationB6/129 Spo11_beta_b_ki/+ is a knock-in hemizygous for the Spo11_bet_b splice isoform. It has been generated by knocking-in the Spo11_beta-b cDNA into the Spo11 locus, destroying the ATG in exon 1.
Phenotypic informationHomozygous:
Unknown.

Heterozygous:
Healthy, most males are fertile beside increased missegregation of XY chromosomes. Frequency of XY asynapsis varies among mice from about 10% to 60%. Females are fully fertile.
Breeding historyKnock-in construct introduced in A9 ES cells (C57BL/6 and 129 background), then mutant mice crossed with Spo11+/- mice with mixed C57BL/6 and 129 backgrounds.
ReferencesNone available
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

IMPC phenotypes (gene matching)
  • abnormal spleen morphology / IMPC
  • increased spleen weight / IMPC
MGI phenotypes (gene matching)
  • abnormal female reproductive system morphology / MGI
  • abnormal ovary morphology / MGI
  • small ovary / MGI
  • impaired ovarian folliculogenesis / MGI
  • absent mature ovarian follicles / MGI
  • abnormal male reproductive system morphology / MGI
  • small testis / MGI
  • small seminiferous tubules / MGI
  • arrest of spermatogenesis / MGI
  • abnormal spermatogenesis / MGI
  • male infertility / MGI
  • female infertility / MGI
  • abnormal gametogenesis / MGI
  • abnormal meiosis / MGI
  • abnormal oogenesis / MGI
  • abnormal reproductive system morphology / MGI
  • abnormal fertility/fecundity / MGI
  • abnormal seminiferous tubule morphology / MGI
  • decreased mature ovarian follicle number / MGI
  • abnormal uterus development / MGI
  • decreased testis weight / MGI
  • decreased ovary weight / MGI
  • azoospermia / MGI
  • abnormal female meiosis / MGI
  • abnormal male meiosis / MGI
  • immune system phenotype / MGI
  • decreased oocyte number / MGI
  • abnormal spermatid morphology / MGI
  • arrest of male meiosis / MGI
  • early reproductive senescence / MGI
  • oocyte degeneration / MGI
  • abnormal primordial ovarian follicle morphology / MGI
  • abnormal chromosomal synapsis / MGI
  • abnormal synaptonemal complex / MGI
  • abnormal double-strand DNA break repair / MGI
  • abnormal X-Y chromosome synapsis during male meiosis / MGI

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).